158 related articles for article (PubMed ID: 32792062)
21. Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin.
Afrouzian M; Al-Lahham R; Patrikeeva S; Xu M; Fokina V; Fischer WG; Abdel-Rahman SZ; Costantine M; Ahmed MS; Nanovskaya T
Biochem Pharmacol; 2018 Oct; 156():467-478. PubMed ID: 30217571
[TBL] [Abstract][Full Text] [Related]
22. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors.
Evseenko DA; Paxton JW; Keelan JA
Drug Metab Dispos; 2007 Apr; 35(4):595-601. PubMed ID: 17237156
[TBL] [Abstract][Full Text] [Related]
23. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
24. Maternal bacterial infections impact expression of drug transporters in human placenta.
Petrovic V; Kojovic D; Cressman A; Piquette-Miller M
Int Immunopharmacol; 2015 Jun; 26(2):349-56. PubMed ID: 25912346
[TBL] [Abstract][Full Text] [Related]
25. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
Vaidya SS; Walsh SW; Gerk PM
Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
[TBL] [Abstract][Full Text] [Related]
26. Maternal obesity is associated with a reduction in placental taurine transporter activity.
Ditchfield AM; Desforges M; Mills TA; Glazier JD; Wareing M; Mynett K; Sibley CP; Greenwood SL
Int J Obes (Lond); 2015 Apr; 39(4):557-64. PubMed ID: 25547282
[TBL] [Abstract][Full Text] [Related]
27. Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure ? Placental transfer across the perfused human placenta.
Grandin FC; Lacroix MZ; Gayrard V; Viguié C; Mila H; de Place A; Vayssière C; Morin M; Corbett J; Gayrard C; Gely CA; Toutain PL; Picard-Hagen N
Chemosphere; 2019 Apr; 221():471-478. PubMed ID: 30654261
[TBL] [Abstract][Full Text] [Related]
28. Effects of chemotherapy on placental development and function using in vitro culture of human primary cytotrophoblasts.
Depoix CL; Colson A; Mhallem-Gziri M; Hubinont C; Debieve F
Invest New Drugs; 2020 Jun; 38(3):547-557. PubMed ID: 31155684
[TBL] [Abstract][Full Text] [Related]
29. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
30. Transplacental Pharmacokinetic Model of Digoxin Based on Ex Vivo Human Placental Perfusion Study.
Kurosawa K; Noguchi S; Nishimura T; Tomi M; Chiba K
Drug Metab Dispos; 2022 Mar; 50(3):287-298. PubMed ID: 34903589
[TBL] [Abstract][Full Text] [Related]
31. Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Transfer Between Adjacent Syncytiotrophoblast Layers.
Fujita A; Noguchi S; Hamada R; Inoue S; Shimada T; Katakura S; Maruyama T; Sai Y; Nishimura T; Tomi M
Pharm Res; 2022 Jul; 39(7):1645-1658. PubMed ID: 35083640
[TBL] [Abstract][Full Text] [Related]
32. Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).
Hofman J; Kučera R; Neumanova Z; Klimes J; Ceckova M; Staud F
Xenobiotica; 2016; 46(5):416-23. PubMed ID: 26364927
[TBL] [Abstract][Full Text] [Related]
33. The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis.
Blazquez AG; Briz O; Gonzalez-Sanchez E; Perez MJ; Ghanem CI; Marin JJ
Toxicol Appl Pharmacol; 2014 May; 277(1):77-85. PubMed ID: 24631341
[TBL] [Abstract][Full Text] [Related]
34. Gestational age-dependent gene expression profiling of ATP-binding cassette transporters in the healthy human placenta.
Imperio GE; Javam M; Lye P; Constantinof A; Dunk CE; Reis FM; Lye SJ; Gibb W; Matthews SG; Ortiga-Carvalho TM; Bloise E
J Cell Mol Med; 2019 Jan; 23(1):610-618. PubMed ID: 30407748
[TBL] [Abstract][Full Text] [Related]
35. ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition.
Mason CW; Buhimschi IA; Buhimschi CS; Dong Y; Weiner CP; Swaan PW
Drug Metab Dispos; 2011 Jun; 39(6):1000-7. PubMed ID: 21430233
[TBL] [Abstract][Full Text] [Related]
36. Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.
Hutson JR; Koren G; Matthews SG
Placenta; 2010 May; 31(5):351-7. PubMed ID: 20347140
[TBL] [Abstract][Full Text] [Related]
37. Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.
Joshi AA; Vaidya SS; St-Pierre MV; Mikheev AM; Desino KE; Nyandege AN; Audus KL; Unadkat JD; Gerk PM
Pharm Res; 2016 Dec; 33(12):2847-2878. PubMed ID: 27644937
[TBL] [Abstract][Full Text] [Related]
38. Multiple drug transporters mediate the placental transport of sulpiride.
Bai M; Ma Z; Sun D; Zheng C; Weng Y; Yang X; Jiang T; Jiang H
Arch Toxicol; 2017 Dec; 91(12):3873-3884. PubMed ID: 28597291
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).
Ishikawa T; Onishi Y; Hirano H; Oosumi K; Nagakura M; Tarui S
Biol Pharm Bull; 2004 Jul; 27(7):939-48. PubMed ID: 15256718
[TBL] [Abstract][Full Text] [Related]
40. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
